Rybelsus represents a breakthrough in diabetes treatment, emerging as an oral medication that integrates easily into daily life. This innovative approach improves the management of type 2 diabetes effectively, offering a simplified option for patients. The compound, semaglutide, acts as a glucagon-like peptide 1 (GLP-1) receptor agonist. It mimics the…